Why the study?
Cardiovascular complications of COVID-19 significantly contribute to morbidity and mortality, and many survivors develop post-COVID-19 syndrome with physical limitations.
This review summarizes the cardiac complications of COVID-19 and provides guidance on cardiopulmonary exercise testing and exercise training for patients recovering from the infection.
Cardiovascular complications drive major COVID-19 morbidity and mortality; leaves open optimal prevention and management strategies.
Since December 2019, the newly emerging coronavirus has become a global pandemic with >250 million people infected and >5 million deaths worldwide. Infection with coronavirus disease-2019 (COVID-19) causes a severe immune response and hypercoagulable state leading to tissue injury, organ damage, and thrombotic events. It is well known that COVID-19 infection predominately affects the lungs; however, the cardiovascular complications of the disease have been a major cause of morbidity and mortality. In addition, patients with cardiovascular disease are vulnerable to contract a severe form of the illness and increased mortality. A significant number of patients who survived the disease may experience post-COVID-19 syndrome with a variety of symptoms and physical limitations. Here, we review the cardiac complications of COVID-19 infection and the results of cardiopulmonary exercise testing and guidelines for exercise training after infection.
No takes yet. Share an insight, caveat, or question.
Smer et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: